Clinical Islet Transplantation Consortium Doctor using a microscope Microscopic matter Doctor in surgery
CIT Consortium Home Who is in the CIT Consortium? What is diabetes What is islet transplantation? What is a clinical trial? Find a CITC trial Links

 

Welcome

The Clinical Islet Transplantation (CIT) Consortium is a network of clinical centers and a data coordinating center established in 2004 to conduct studies of islet transplantation in patients with type 1 diabetes.

Studies conducted by the CIT Consortium will focus on improving the safety and long-term success of methods for transplanting islets, the insulin-producing cells of the pancreas, in people whose own islets have been destroyed by the autoimmune process that characterizes type 1 diabetes.

The network includes the following centers:

University of Miami
Miami, Florida		 University of Minnesota
Minneapolis, Minnesota
University of Pennsylvania
Philadelphia, Pennsylvania		 Emory University
Atlanta, Georgia
Northwestern University
Chicago, Illinois		 University of Alberta
Edmonton, Alberta, Canada
University of California
San Francisco, California		 University of Illinois at Chicago
Chicago, Illinois
Uppsala University
Uppsala, Sweden		 Karolinska University
Stockholm, Sweden
University Hospital Rikshospitalet
Oslo, Norway 		 

Please visit our Web site frequently, information is updated on a regular basis.

For information on how to participate in a CITC study, please contact 1-877-isletstudy or complete the questionnaire below:
Do I qualify?


See if you may be eligible to participant in a clinical study

For information on how to participate in a CITC study, contact 1-877-isletstudy or complete the questionnaire below:

1 Are you screening for yourself?  Yes No
CONTINUE


 

Home   |   Printer Friendly Version       
Department of Health and Human Services National Institutes of Health (NIH) National Institute of Allergy and Infectious Disease (NIAID) National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)